Roivant Sciences Ltd. ( ROIV - Free Report ) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.21. This compares to loss of $0.26 per share a year ago. These figures are adjusted for non-recurring items.